Patent ID: 11857560
Assignee: EMORY UNIVERSITY
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  C  Y | IPC A  C

Claim 11:
12. The method of claim 11, wherein the viral infection comprises infection with a virus selected from the group consisting of human adenovirus, BK virus, chikungunya, coxsackie A virus, human coronavirus, Middle East respiratory syndrome (MERS) coronavirus, severe acute respiratory syndrome (SARS) coronavirus, cytomegalovirus, dengue virus, ebola virus, California encephalitis virus, Eastern equine encephalitis virus, Western equine encephalitis virus, Venezuelan equine encephalitis virus, Epstein-Barr virus, hantavirus, hepatitis A, hepatitis B, hepatitis C, hepatitis D, hepatitis E, herpes lymphotropic virus, herpes simplex virus 1, herpes simplex virus 2, Karposi's sarcoma-associated herpes virus, human immunodeficiency virus (HIV), influenza A virus, influenza B virus, influenza C virus, John Cunningham (JC) virus, lymphocytic choriomeningitis virus, Marburg virus, measles virus, molluscum contagiosum virus, mumps virus, norovirus, human papillomavirus, parvovirus B19, Merkel cell polyomavirus, rabies virus, respiratory syncytial virus, rinderpest virus, roseolovirus, rotavirus A, rotavirus B, rotavirus C, rotavirus D, rotavirus E, varicella zoster virus, and yellow fever virus, or a combination thereof.